Predicate |
Object |
contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
endingPage |
186 |
issn |
1559-0100 1355-008X |
issueIdentifier |
2 |
pageRange |
181-186 |
publicationName |
Endocrine |
startingPage |
181 |
bibliographicCitation |
Yim KL. Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours. Endocrine. 2011 Oct;40(2):181–6. doi: 10.1007/s12020-011-9513-y. PMID: 21870172. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcb2ff05f91c6766a57fe353d947049b |
date |
2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1007/s12020-011-9513-y https://pubmed.ncbi.nlm.nih.gov/21870172 |
isPartOf |
https://portal.issn.org/resource/ISSN/1559-0100 https://portal.issn.org/resource/ISSN/1355-008X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20589 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours |
discusses |
http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0448793 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0443627 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0018276 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10250 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID464 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 |